Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization
Sign Up to like & getrecommendations! Published in 2018 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-018-1962-8
Abstract: PurposeTo retrospectively compare early response to yttrium-90 radioembolization (Y90) according to volumetric iodine uptake (VIU) changes, Response Evaluation Criteria In Solid Tumor 1.1 (RECIST 1.1) and modified RECIST (mRECIST) in patients with intermediate-advanced hepatocellular carcinoma… read more here.
Keywords: volumetric iodine; response; yttrium radioembolization; iodine uptake ... See more keywords
Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate–advanced hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000026958
Abstract: Abstract Background: Hepatocellular carcinoma (HCC) ranks as the sixth most common cancer and the second leading cause of cancer-related death worldwide, local and systemic therapies are beneficial for those who have more advanced disease or… read more here.
Keywords: hepatocellular carcinoma; tace sorafenib; sorafenib; intermediate advanced ... See more keywords
Efficacy of oncolytic virus in the treatment of intermediate-to-advanced solid tumors: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Virology"
DOI: 10.1128/jvi.00640-25
Abstract: ABSTRACT This meta-analysis assessed oncolytic virus therapy’s efficacy for intermediate-to-advanced solid tumors. We systematically searched PubMed, Cochrane Library, and Embase databases until March 6, 2025. Our review included 87 studies, involving 5,385 individuals, encompassing 75… read more here.
Keywords: meta; intermediate advanced; oncolytic virus; solid tumors ... See more keywords
Pronoun interpretation in intermediate-advanced L2 English speakers: L2 to L1 cross-linguistic effects
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Bilingualism"
DOI: 10.1177/13670069241260941
Abstract: Aims and objectives: L2 learners who speak a null subject (L1 Spanish) and a non-null subject language (L2 English) may experience cross-linguistic interference from the L2 on L1 pronoun interpretation. In this study, we test… read more here.
Keywords: intermediate advanced; language; pronoun interpretation; english speakers ... See more keywords
Development and validation of nomograms to provide individualized predictions of survival benefits from surgery in patients with intermediate/advanced hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16112
Abstract: e16112Background: According to the BCLC treatment guidelines, surgery is not recommended for intermediate/advanced hepatocellular carcinoma (HCC). In real world, however, liver resections are often... read more here.
Keywords: hepatocellular carcinoma; surgery; development validation; advanced hepatocellular ... See more keywords
A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e16171
Abstract: e16171 Background: Recent phase III clinical trial ZGDH3 and several real-world studies have demonstrated the potential of Donafenib in improving overall survival (OS) in advanced HCC. This study aims to evaluate the efficacy and safety… read more here.
Keywords: donafenib combined; tace; intermediate advanced; efficacy ... See more keywords
Transcatheter Arterial Chemoembolization in Combination With High-Intensity Focused Ultrasound for Intermediate and Advanced Hepatocellular Carcinoma: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.797349
Abstract: Background The study was conducted to explore whether high-intensity focused ultrasound (HIFU) can improve the effect of transcatheter arterial chemoembolization (TACE) in intermediate and advanced hepatocellular carcinoma (HCC). Methods PubMed, Embase, Cochrane Library, Web of… read more here.
Keywords: meta analysis; intermediate; combination; intermediate advanced ... See more keywords
Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.816198
Abstract: Objective Camrelizumab is a newly developed program-death receptor one inhibitor; the real-world evidence about its application in hepatocellular carcinoma (HCC) treatment is lacking. Therefore, this prospective, multi-center, real-world study evaluated the efficacy and safety of… read more here.
Keywords: pfs; camrelizumab plus; intermediate advanced; camrelizumab ... See more keywords
Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v25.i27.3607
Abstract: BACKGROUND Hepatocellular carcinoma (HCC) represents the sixteenth most frequent cancer in Argentina. The rise of new therapeutic modalities in intermediate-advanced HCC opens up a new paradigm for the treatment of HCC. AIM To describe real-life… read more here.
Keywords: hepatocellular carcinoma; tace; treatment; bclc patients ... See more keywords
Immune therapies in intermediate-advanced unresectable hepatocellular carcinoma: Changing the therapeutic landscape
Sign Up to like & getrecommendations! Published in 2025 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v31.i14.103267
Abstract: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. A substantial proportion of patients are diagnosed with advanced or intermediate-advanced stage disease at presentation and are often ineligible for curative surgery.… read more here.
Keywords: intermediate advanced; hepatocellular carcinoma; immune therapies; advanced stage ... See more keywords